Chen, K., Huang, W., Wang, J., Xu, H., Ruan, L., Li, Y., . . . Li, X. (2023). Increased serum fibroblast growth factor 21 levels are associated with adverse clinical outcomes after intracerebral hemorrhage. Frontiers in Neuroscience, 17, . https://doi.org/10.3389/fnins.2023.1117057
Chicago Style (17th ed.) CitationChen, Keyang, et al. "Increased Serum Fibroblast Growth Factor 21 Levels Are Associated with Adverse Clinical Outcomes After Intracerebral Hemorrhage." Frontiers in Neuroscience 17 (2023). https://doi.org/10.3389/fnins.2023.1117057.
MLA (9th ed.) CitationChen, Keyang, et al. "Increased Serum Fibroblast Growth Factor 21 Levels Are Associated with Adverse Clinical Outcomes After Intracerebral Hemorrhage." Frontiers in Neuroscience, vol. 17, 2023, https://doi.org/10.3389/fnins.2023.1117057.